Clinical Trials in Maryland
Here are the 6 most popular medical studies in Maryland Clinical Trials
Cancer Vaccine
Trastuzumab + Trastuzumab Emtansine + TPIV100 + Pertuzumab + Sargramostim for Stage II-III Breast Cancer
Recruiting0 awardsPhase 2
Baltimore, Maryland
This trial is studying whether a combination of TPIV100 and sargramostim is effective in treating patients with HER2 positive, stage II-III breast cancer that has residual disease after chemotherapy.
Chemotherapy
Chemo-Immunotherapy + Durvalumab + Ceralasertib for Small Cell Lung Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing a new treatment for small cell lung cancer that has not yet been approved. The goal is to see if it can help patients live longer without their cancer progressing.
Popular filter options for Maryland Clinical Trials trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
BI 1015550 for Interstitial Lung Disease
Recruiting1 awardPhase 3
Philadelphia, Pennsylvania
This trialis testing a medicine to help people with Progressive Fibrosing Interstitial Lung Diseases. Participants take tablets and visit the study site for up to two and a half years for regular tests and checkups.
Checkpoint Inhibitor
Nivolumab + Ipilimumab + GM-CSF for Advanced Melanoma
Recruiting1 awardPhase 2 & 3
Washington, District of Columbia
This trial is studying nivolumab and ipilimumab to see how well they work with or without sargramostim in treating patients with stage III-IV melanoma that cannot be removed by surgery.
Alkylating agents
Individualized Therapy for Nasopharyngeal Cancer
Recruiting1 awardPhase 2 & 3
Baltimore, Maryland
This trial will test whether a blood biomarker can help doctors identify which patients will benefit from different types of chemotherapy after radiation therapy for nasopharyngeal cancer.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Stent Graft System
Aortic Stent Graft System for Aortic Conditions
Recruiting1 award20 criteria
Baltimore, Maryland
This trial is testing a new stent graft system for treating aortic arch lesions. The stent graft will have a proximal landing zone in the ascending aorta and a brachiocephalic trunk native landing zone.
Checkpoint Inhibitor
Nivolumab + Ipilimumab + GM-CSF for Advanced Melanoma
Recruiting1 awardPhase 2 & 3
Washington, District of Columbia
This trial is studying nivolumab and ipilimumab to see how well they work with or without sargramostim in treating patients with stage III-IV melanoma that cannot be removed by surgery.
View More Maryland Clinical Trials Trials
See another 83 many medical studies focused on Maryland Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.